Ledger.Open graph →
SEC Form D · filed April 5, 2022

Maxwell Biosciences, Inc

Offering
$14.8M
Sold
$10.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Austin, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Joshua Mcclure · Austin, TXExec · DirectorPraveen Tyle · Austin, TXDirectorAnnelise Barron · Austin, TXDirectorTheodore Moskovitz · Austin, TXDirectorAjitkumar (Adam) F. Patel · Macon, GADirectorDipesh R. Patel · Macon, GAExec · DirectorManeklal G. Patel · Macon, GADirectorChristopher Johns · Austin, TXDirectorBrandon Reeves · Torrance, CADirectorChristopher Power · Torrance, CADirectorKatherine Boyle · Torrance, CAExec · DirectorTheodore Moskovitz · Austin, TXDirectorChristopher Johns · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗